Contact PI/Project LeaderEDDEN, RICHARD ANTHONY EDWARD
Awardee OrganizationJOHNS HOPKINS UNIVERSITY
Description
Abstract Text
Project Summary
Hadamard-encoded edited MRS allows simultaneous in vivo detection of multiple low-concentration
neurometabolites in a single experiment. Methods developed in the last funded period of this grant are being
applied in the HBCD study, a large national study of childhood development (~7,000 infants). In this renewal
period, we will acquire the same acquisition protocol in a whole-lifespan cohort in order to reveal
neurochemical changes in development and aging. Methodologically, we will then extend the utility of edited
MRS into challenging areas of the brain by addressing the long-standing issue of out-of-voxel (OOV) echoes.
We will optimize acquisitions to reduce the impact of OOV echoes for each challenging region and develop
modeling strategies to minimize their impact on metabolite quantification. We will also develop intelligent
acquisitions that can detect OOV signals in real-time as the sequence is being acquired and adjust the
acquisition responsively to reduce OOV signals. Finally, we will continue the on-going work to disseminate
methods developed during prior grant periods, upgrading code as scanners update and porting new advances
back into older code so collaborators can benefit.
Public Health Relevance Statement
Project Narrative
Edited magnetic resonance spectroscopy (MRS) allows us to measure levels of biologically interesting
chemicals in the brain; this project has allowed us to develop edited MRS methods with researchers around
the world. In this renewal period, we will study these brain chemicals in a cohort that covers the entire lifespan,
address the longstanding technical challenge of unwanted signals, and continue to share methods with
collaborators.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
001910777
UEI
FTMTDMBR29C7
Project Start Date
01-August-2013
Project End Date
31-March-2027
Budget Start Date
01-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$628,820
Direct Costs
$451,768
Indirect Costs
$177,052
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$628,820
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB016089-10
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB016089-10
Patents
No Patents information available for 5R01EB016089-10
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB016089-10
Clinical Studies
No Clinical Studies information available for 5R01EB016089-10
News and More
Related News Releases
No news release information available for 5R01EB016089-10
History
No Historical information available for 5R01EB016089-10
Similar Projects
No Similar Projects information available for 5R01EB016089-10